vs
百胜餐饮集团（LCUT）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是百胜餐饮集团的1.1倍（$219.9M vs $204.1M），百胜餐饮集团净利率更高（8.9% vs -1.0%，领先9.9%），Orthofix Medical Inc.同比增速更快（2.0% vs -5.2%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $2.6M），过去两年百胜餐饮集团的营收复合增速更高（19.8% vs 8.0%）
百胜餐饮集团是美国跨国快餐企业，1977年百事可乐收购肯德基、必胜客、塔可Bell后将其整合为旗下子公司，1997年百事剥离该业务板块后正式独立为百胜集团。集团目前运营肯德基、必胜客、塔可Bell、哈比特汉堡等多个餐饮品牌，同时布局相关餐饮科技业务，门店网络遍布全球多个国家和地区。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
LCUT vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.1倍
$204.1M
营收增速更快
OFIX
高出7.1%
-5.2%
净利率更高
LCUT
高出9.9%
-1.0%
自由现金流更多
OFIX
多$14.2M
$2.6M
两年增速更快
LCUT
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $204.1M | $219.9M |
| 净利润 | $18.2M | $-2.2M |
| 毛利率 | 38.6% | 71.1% |
| 营业利润率 | 9.8% | 0.2% |
| 净利率 | 8.9% | -1.0% |
| 营收同比 | -5.2% | 2.0% |
| 净利润同比 | 103.5% | 92.4% |
| 每股收益（稀释后） | $0.83 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LCUTOFIX
| Q4 25 | $204.1M | $219.9M | ||
| Q3 25 | $171.9M | $205.6M | ||
| Q2 25 | $131.9M | $203.1M | ||
| Q1 25 | $140.1M | $193.6M | ||
| Q4 24 | $215.2M | $215.7M | ||
| Q3 24 | $183.8M | $196.6M | ||
| Q2 24 | $141.7M | $198.6M | ||
| Q1 24 | $142.2M | $188.6M |
净利润LCUTOFIX
| Q4 25 | $18.2M | $-2.2M | ||
| Q3 25 | $-1.2M | $-22.8M | ||
| Q2 25 | $-39.7M | $-14.1M | ||
| Q1 25 | $-4.2M | $-53.1M | ||
| Q4 24 | $8.9M | $-29.1M | ||
| Q3 24 | $344.0K | $-27.4M | ||
| Q2 24 | $-18.2M | $-33.4M | ||
| Q1 24 | $-6.3M | $-36.0M |
毛利率LCUTOFIX
| Q4 25 | 38.6% | 71.1% | ||
| Q3 25 | 35.1% | 72.2% | ||
| Q2 25 | 38.6% | 68.7% | ||
| Q1 25 | 36.1% | 62.8% | ||
| Q4 24 | 37.7% | 69.0% | ||
| Q3 24 | 36.7% | 68.7% | ||
| Q2 24 | 38.5% | 67.8% | ||
| Q1 24 | 40.5% | 67.5% |
营业利润率LCUTOFIX
| Q4 25 | 9.8% | 0.2% | ||
| Q3 25 | 3.9% | -8.3% | ||
| Q2 25 | -28.2% | -7.9% | ||
| Q1 25 | 0.8% | -25.2% | ||
| Q4 24 | 7.2% | -5.3% | ||
| Q3 24 | 4.7% | -9.6% | ||
| Q2 24 | 0.8% | -12.5% | ||
| Q1 24 | 1.3% | -15.6% |
净利率LCUTOFIX
| Q4 25 | 8.9% | -1.0% | ||
| Q3 25 | -0.7% | -11.1% | ||
| Q2 25 | -30.1% | -6.9% | ||
| Q1 25 | -3.0% | -27.4% | ||
| Q4 24 | 4.1% | -13.5% | ||
| Q3 24 | 0.2% | -13.9% | ||
| Q2 24 | -12.8% | -16.8% | ||
| Q1 24 | -4.4% | -19.1% |
每股收益（稀释后）LCUTOFIX
| Q4 25 | $0.83 | $-0.05 | ||
| Q3 25 | $-0.05 | $-0.57 | ||
| Q2 25 | $-1.83 | $-0.36 | ||
| Q1 25 | $-0.19 | $-1.35 | ||
| Q4 24 | $0.41 | $-0.76 | ||
| Q3 24 | $0.02 | $-0.71 | ||
| Q2 24 | $-0.85 | $-0.88 | ||
| Q1 24 | $-0.29 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.3M | $82.0M |
| 总债务越低越好 | $135.0M | — |
| 股东权益账面价值 | $202.3M | $450.0M |
| 总资产 | $572.6M | $850.6M |
| 负债/权益比越低杠杆越低 | 0.67× | — |
8季度趋势，按日历期对齐
现金及短期投资LCUTOFIX
| Q4 25 | $4.3M | $82.0M | ||
| Q3 25 | $12.1M | $62.9M | ||
| Q2 25 | $12.0M | $65.6M | ||
| Q1 25 | $10.4M | $58.0M | ||
| Q4 24 | $2.9M | $83.2M | ||
| Q3 24 | $6.0M | $30.1M | ||
| Q2 24 | $3.4M | $26.4M | ||
| Q1 24 | $4.6M | $27.0M |
总债务LCUTOFIX
| Q4 25 | $135.0M | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | $142.5M | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益LCUTOFIX
| Q4 25 | $202.3M | $450.0M | ||
| Q3 25 | $184.6M | $442.5M | ||
| Q2 25 | $185.8M | $458.3M | ||
| Q1 25 | $225.7M | $458.3M | ||
| Q4 24 | $229.9M | $503.1M | ||
| Q3 24 | $220.9M | $525.9M | ||
| Q2 24 | $219.8M | $546.0M | ||
| Q1 24 | $223.7M | $570.3M |
总资产LCUTOFIX
| Q4 25 | $572.6M | $850.6M | ||
| Q3 25 | $581.1M | $832.6M | ||
| Q2 25 | $551.9M | $837.2M | ||
| Q1 25 | $594.6M | $823.1M | ||
| Q4 24 | $634.3M | $893.3M | ||
| Q3 24 | $668.7M | $867.9M | ||
| Q2 24 | $617.0M | $882.0M | ||
| Q1 24 | $602.7M | $906.0M |
负债/权益比LCUTOFIX
| Q4 25 | 0.67× | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | 0.62× | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.7M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $2.6M | $16.8M |
| 自由现金流率自由现金流/营收 | 1.3% | 7.6% |
| 资本支出强度资本支出/营收 | 0.6% | 4.9% |
| 现金转化率经营现金流/净利润 | 0.21× | — |
| 过去12个月自由现金流最近4个季度 | $3.3M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流LCUTOFIX
| Q4 25 | $3.7M | $27.7M | ||
| Q3 25 | $-22.2M | $12.4M | ||
| Q2 25 | $9.3M | $11.6M | ||
| Q1 25 | $16.7M | $-18.4M | ||
| Q4 24 | $20.3M | $23.7M | ||
| Q3 24 | $-22.7M | $11.7M | ||
| Q2 24 | $10.4M | $9.0M | ||
| Q1 24 | $10.5M | $-18.6M |
自由现金流LCUTOFIX
| Q4 25 | $2.6M | $16.8M | ||
| Q3 25 | $-22.7M | $2.5M | ||
| Q2 25 | $8.2M | $4.5M | ||
| Q1 25 | $15.1M | $-25.1M | ||
| Q4 24 | $19.7M | $15.2M | ||
| Q3 24 | $-23.2M | $6.3M | ||
| Q2 24 | $9.9M | $-360.0K | ||
| Q1 24 | $9.9M | $-29.1M |
自由现金流率LCUTOFIX
| Q4 25 | 1.3% | 7.6% | ||
| Q3 25 | -13.2% | 1.2% | ||
| Q2 25 | 6.2% | 2.2% | ||
| Q1 25 | 10.8% | -13.0% | ||
| Q4 24 | 9.1% | 7.0% | ||
| Q3 24 | -12.6% | 3.2% | ||
| Q2 24 | 7.0% | -0.2% | ||
| Q1 24 | 7.0% | -15.4% |
资本支出强度LCUTOFIX
| Q4 25 | 0.6% | 4.9% | ||
| Q3 25 | 0.3% | 4.8% | ||
| Q2 25 | 0.9% | 3.5% | ||
| Q1 25 | 1.1% | 3.5% | ||
| Q4 24 | 0.3% | 4.0% | ||
| Q3 24 | 0.3% | 2.7% | ||
| Q2 24 | 0.4% | 4.7% | ||
| Q1 24 | 0.4% | 5.6% |
现金转化率LCUTOFIX
| Q4 25 | 0.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.28× | — | ||
| Q3 24 | -65.89× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LCUT
| Kitchenware | $114.3M | 56% |
| Tableware | $41.7M | 20% |
| Home Solutions | $29.4M | 14% |
| Other | $18.8M | 9% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
